(:MBTCU)

Apr 17, 2024 02:25 pm ET
Nocturne Acquisition Corporation Announces Termination and Liquidation of Trust Account
SANTA ANA, CA / ACCESSWIRE / April 17, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that it will be unable to complete an initial business combination with Cognos Therapeutics, Inc. and intends to liquidate the Trust Account.
Mar 19, 2024 08:31 am ET
Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting Date
SANTA ANA, CA / ACCESSWIRE / March 19, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that the Board of Directors has voted in favor of postponing the meeting date for the Extraordinary General Meeting that was to be held on March 19, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. ("Cognos"). The Extraordinary General Meeting will now be held virtually on April 2, 2024 at 9:00 a.m. Eastern Time, and the Company plans to continue to solicit proxies from shareholders during
Feb 27, 2024 08:31 am ET
Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting Date
SANTA ANA, CA / ACCESSWIRE / February 27, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that the Board of Directors has voted in favor of postponing the meeting date for the Extraordinary General Meeting that was to be held on February 27, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. ("Cognos"). The Extraordinary General Meeting will now be held virtually on March 19, 2024 at 9:00 a.m. Eastern Time, and the Company plans to continue to solicit proxies from shareholders
Feb 05, 2024 08:31 am ET
Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting
SANTA ANA, CA / ACCESSWIRE / February 5, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that the Board of Directors has voted in favor of a second postponement of the meeting date for the Extraordinary General Meeting that was to be held on January 30, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. The Extraordinary General Meeting that was postponed until February 6, 2024 has been postponed further and will now be held virtually on February 27, 2024 at 9:00 a.m. Eastern Time. The C
Jan 30, 2024 08:31 am ET
Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting
SANTA ANA, CA / ACCESSWIRE / January 30, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that the Board of Directors has voted in favor of postponing the meeting date for the Extraordinary General Meeting that was to be held on January 30, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. The Extraordinary General Meeting will now be held virtually on February 6, 2024 at 10:00 a.m. Eastern Time, and the Company plans to continue to solicit proxies from shareholders during the period pri
Sep 20, 2023 06:35 pm ET
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) ("Nocturne") and Cognos Therapeutics, Inc. (“Cognos”) today announced the engagement of Chardan, a leading global investment bank, in the role of capital markets advisor to Nocturne in...
Aug 16, 2023 08:05 am ET
Nocturne Acquisition Corporation Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Cognos
Transaction Expected to Accelerate the Research and Advancement of Cognos' Proprietary and Innovative Implantable Drug Delivery Pump to Improve Outcomes for Treatment of Brain Cancers and Other Neurological Diseases
May 30, 2023 08:30 am ET
Nocturne Acquisition Corporation Announces Receipt of a Second Notification from Nasdaq
WILMINGTON, DE / ACCESSWIRE / May 30, 2023 / Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) (the "Company", "MBTC"), today announced that it has received a second notification (the "Second Notification") on May 24, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the "Form 10-Q"), a
Jan 03, 2023 08:31 am ET
Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation
WILMINGTON, DE and INGLEWOOD, CA / ACCESSWIRE / January 3, 2023 / Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) ("Nocturne"), a publicly-traded special purpose acquisition company, today announced execution of a definitive business combination agreement with Cognos Therapeutics, Inc. ("Cognos"), a medical technology company focused on developing unique, radically advanced devices delivering drugs for the treatment of neurological diseases including brain and spinal cancers, neurodegenerative disorders (such as Alzheimer's and Parkinson's dise
Jul 05, 2022 09:35 am ET
Nocturne Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination
WILMINGTON, DE / ACCESSWIRE / July 5, 2022 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that an aggregate of $1,150,000 (the "Extension Payment") has been deposited into the Company's trust account for its public shareholders, representing $0.10 per public share, which enables the Company to extend the period of time it has to consummate its initial business combination by three months from July 5, 2022 to October 5, 2022 (the "Extension").
Apr 05, 2022 04:01 pm ET
Nocturne Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination
WILMINGTON, DE / ACCESSWIRE / April 5, 2022 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that an aggregate of $1,150,000 (the "Extension Payment") has been deposited into the Company's trust account for its public shareholders, representing $0.10 per public share, which enables the Company to extend the period of time it has to consummate its initial business combination by three months from April 5, 2022 to July 5, 2022 (the "Extension").
Jun 04, 2021 04:05 pm ET
Nocturne Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
LA JOLLA, CA / ACCESSWIRE / June 4, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU) (the "Company") today announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria establishe
Apr 29, 2021 04:01 pm ET
Nocturne Acquisition Corporation Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 3, 2021
LA JOLLA, CA / ACCESSWIRE / April 29, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU) (the "Company" or "MBTC") announced that, commencing May 3, 2021, holders of the units sold in the Company's initial public offering of 11,500,000 units, may elect to separately trade shares of the Company's ordinary shares and rights included in the units. The ordinary shares and rights that are separated will trade on the Nasdaq Capital Market under the symbols "MBTC" and "MBTCR," respectively. Those units not separated will continue to trade on
Apr 14, 2021 04:25 pm ET
Nocturne Acquisition Corporation Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
LA JOLLA, CA / ACCESSWIRE / April 14, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU), the "Company") announced today that the underwriters in its initial public offering, pursuant to the terms of the underwriting agreement, fully exercised their over-allotment option and, on April 14, 2021, closed the purchase of an additional 1,500,000 units in connection with its initial public offering at $10.00 per unit, generating additional gross proceeds of $15,000,000 and bringing the total gross proceeds of the initial public offering to $115,000,000. Each unit consi
Apr 05, 2021 04:01 pm ET
Nocturne Acquisition Corporation Announces Closing of $100 Million Initial Public Offering
LA JOLLA, CA / ACCESSWIRE / April 5, 2021 / Nocturne Acquisition Corporation (the "Company"), a special purpose acquisition company, today announced the closing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units began trading on The Nasdaq Capital Market ("Nasdaq") on March 31, 2021, under the ticker symbol "MBTCU".
Mar 31, 2021 08:31 am ET
Nocturne Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering
LA JOLLA, CA / ACCESSWIRE / March 31, 2021 / Nocturne Acquisition Corporation (the "Company"), a special purpose acquisition company, today announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market ("Nasdaq") and will begin trading on March 31, 2021, under the ticker symbol "MBTCU".

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.

Learn More